semaglutide cv outcomes 🔴Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of death/MI/stroke regardless of baseline CKD severity in participants Semaglutide and Cardiovascular Outcomes in

The latest data shows where the agency is focusing and what companies should be preparing for now.

Our Winona reviews share whether this HRT service for menopause is effective, safe, and affordable.

We are proud to share that Professor Jens Juul Holst from the Department of Biomedical Sciences has been awarded the Lipid Science Prize 2026 by the Camurus Lipid Research Foundation in Malm. Jens receives the prize in recognition of his groundbreaking discovery of the GLP1 hormone back in 1986 - a finding that laid the foundation for diabetes and weightloss medications used by millions worldwide

Wondering if these supplements deliver on energy, digestion, and wellness

- 7.2% of GLP-1 users received a gout diagnosis, compared with 6.6% of nonusersabout a 12% higher risk

This article explains the benefits of not waiting to learn about your GLP-1 options.